Madelene Borgvall

Madelene Borgvall has a diverse work experience spanning different industries and roles. Madelene is currently an Associate Director and Global Brand Lead Haemophilia at Sobi - Swedish Orphan Biovitrum AB (publ), starting in 2023. From 2019 to 2023, they worked as a Global Launch Lead at Recordati Rare Diseases. Prior to that, they were an International Marketing Manager at Nordic Pharmaceutical Group from 2016 to 2019. Madelene also worked at Takeda from 2013 to 2016, first as a Senior Product Manager and then as an International Product Manager at Nordic Pharmaceutical Group in 2013. Madelene started their career at CROMA-PHARMA in 2007, where they served as a Marketing Manager, overseeing Ophthalmology, Rheumatology, and Aesthetics. Madelene also worked at Allergan as a Marketing Assistant from 2004 to 2006.

Madelene Borgvall has a diverse education history in various fields. In 2022, they completed courses in Sales Management & Coaching as well as Consultative Selling Train the Trainer at Management Centre Europe. Madelene also took a course in The Pharma Forecasting Course at CELforPharma in the same year. In 2021, they obtained a training degree in Strategy and planning for Commercial Launch from CELforPharma. Other educational credentials include a Certification in "The Customer Focus in action" from ESSEC Business School in 2014, a Diploma in Sales Representative in the Pharmaceutical Industry from SupSanté in 2012, an MBA in Management and Marketing of luxury products from MBA ESG in 2007, a Master's degree in Marketing and Business Management from IDRAC Business School in 2006, and a Bachelor's degree in Commercial Action from Faculté des Métiers in 2004. Additionally, they obtained certifications in The Pharma Forecasting Course and Strategy and Planning for Commercial Launch Success in Pharma from CELforPharma.